APHY - Assured Pharmacy to Present at Anda's 2012

APHY - Assured Pharmacy to Present at Anda's 2012 Supply Chain Symposium 

Assured Pharmacy (PC) (USOTC:APHY) 

Tuesday 20 March 2012 


Assured Pharmacy (Pinksheets: APHY), a leading specialty pharmacy group providing prescription medications to sufferers of chronic pain, will present at Anda's 2012 Supply Chain Symposium on Thursday, April 19th at the PGA National Resort and Spa in Palm Beach Gardens, Florida. Assured Pharmacy has been asked to present concepts relating to best practices in dispensing controlled substances at pharmacies. 

Anda was established in 1992 to service the pharmaceutical purchasing needs for pharmacies and physician offices. Anda has positioned itself as the fourth largest supplier of generic pharmaceuticals within the U.S. With over 8,500 items in stock, Anda's product assortment also includes brands and specialty pharmaceuticals, vaccines, injectables, medical/surgical supplies and OTCs/Vitamins. Anda ships to over 65,000 pharmacy related, physician and warehouse locations, to all classes of trade. 

"We look forward to the opportunity to present at Anda's 5th Annual Supply Chain Symposium," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "We are honored to be recognized as a leader in compliance by an organization as a prestigious as Anda as well as our peers." 

About Assured Pharmacy, Inc.Assured Pharmacy, Inc. is a growing provider of specialty pharmacy services to patients and physicians in the treatment of chronic pain. Through its network of specialty pharmacies, the Company predominantly dispenses highly regulated pain medications to sufferers of chronic pain, while stringently adhering to federal and state reporting requirements for both patients and physicians. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The majority of the Company's business is derived from repeat visits from its customer base of physician-referred chronic pain patients. "Walk-in" prescriptions from physicians are limited. The Company currently has five operating pharmacies which are wholly owned and including its fifth operating pharmacy recently opened in the Kansas City metropolitan area. 

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise. 



Investor Contact: 


Erika Moran/Adam Holdsworth 
The Investor Relations Group 
11 Stone St. 3rd Floor 
New York, NY 
212-825-3210 


SOURCE Assured Pharmacy, Inc.